Immunovia AB (OSTO:IMMNOV)
kr 1.246 0.401 (47.46%) Market Cap: 210.93 Mil Enterprise Value: 182.88 Mil PE Ratio: 0 PB Ratio: 5.77 GF Score: 36/100

Nine Months 2020 Immunovia AB (publ) Earnings Call Transcript

Nov 12, 2020 / 03:30PM GMT
Release Date Price: kr75.15 (-3.66%)
Operator

Hello, and welcome to the Immunovia third Quarter interim report. My name is Patrick, and I will be your coordinator of today's event. (Operator Instructions)

I am now handing you over to your host, Julie Silber, Director of Investor Relations, to begin today's conference. Thank you.

Julie Silber;publ;Director of IR
Immunovia AB

()-

Thank you, Patrick. Welcome to the call. Before we begin, I'd like to give a quick reminder to our listeners. Today's webinar and call, management may make forward-looking statements that involve known and unknown risks, uncertainties and other important factors beyond the company's control that could cause the company's actual results, performance or achievements to be materially different from the expected results, performance and achievements expressed or implied by such forward-looking statements.

These statements are subject to risks and uncertainties that could cause actual results to differ materially from those contained in the forward-looking statements. Actual results and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot